Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 587Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Study of drug–Drug interactions among the hypertensive patients in a tertiary care teaching hospital

Subramanian Ansha, Adhimoolam Mangaiarkkarasi, Kannan Suresh

Year : 2018| Volume: 9| Issue : 1 | Page no: 9-14

   This article has been cited by
 
1 Drug-Drug interaction among admitted patients at primary, district and referral hospitals’ medical wards in East Gojjam Zone, Amhara Regional State, Ethiopia
Zenaw Tessema, Desalegn Yibeltal, Muluken Wubetu, Bekalu Dessie, Yalew Molla
SAGE Open Medicine. 2021; 9: 2050312121
[Pubmed]  [Google Scholar] [DOI]
2 Polypharmacy in the Management of Arterial Hypertension—Friend or Foe?
Camelia Cristina Diaconu, Matei-Alexandru Cozma, Elena-Codru?a Dobrica, Gina Gheorghe, Alexandra Jichitu, Vlad Alexandru Ionescu, Alina Crengu?a Nicolae, Cristina Manuela Dragoi, Mihnea-Alexandru Gaman
Medicina. 2021; 57(12): 1288
[Pubmed]  [Google Scholar] [DOI]
3 Prevalence and Clinical Significance of Drug–Drug and Drug–Dietary Supplement Interactions among Patients Admitted for Cardiothoracic Surgery in Greece
Marios Spanakis,Maria Melissourgaki,George Lazopoulos,Athina E. Patelarou,Evridiki Patelarou
Pharmaceutics. 2021; 13(2): 239
[Pubmed]  [Google Scholar] [DOI]
4 Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors
Dominique A. Garrison,Zahra Talebi,Eric D. Eisenmann,Alex Sparreboom,Sharyn D. Baker
Pharmaceutics. 2020; 12(9): 856
[Pubmed]  [Google Scholar] [DOI]
5 Potential drug–drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria
Sidra Noor,Mohammad Ismail,Faiza Khadim
Malaria Journal. 2020; 19(1)
[Pubmed]  [Google Scholar] [DOI]
6 The prevalence and severity of potential drug- drug interactions among polypharmacy patients in Jordan
Mohammad B. Nusair,Sayer I. Al-azzam,Rasha. M. Arabyat,Haneen A. Amawi,Karem H. Alzoubi,Asma Rabah
Saudi Pharmaceutical Journal. 2019;
[Pubmed]  [Google Scholar] [DOI]
7 Assessment of Pharmacokinetic Drug–Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited
Uwe Fuhr,Chih-hsuan Hsin,Xia Li,Wafaâ Jabrane,Fritz Sörgel
Annual Review of Pharmacology and Toxicology. 2019; 59(1): 507
[Pubmed]  [Google Scholar] [DOI]
8 Potential drug-drug interactions among pneumonia patients: do these matter in clinical perspectives?
Sidra Noor,Mohammad Ismail,Zahid Ali
BMC Pharmacology and Toxicology. 2019; 20(1)
[Pubmed]  [Google Scholar] [DOI]
9 Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety
Sidra Noor,Mohammad Ismail,Fahadullah Khan
Frontiers in Pharmacology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
10 Attitude and perception of medical interns about antimicrobial resistance: a multi center cross-sectional study in Ethiopia
Amanual Getnet Mersha
Antimicrobial Resistance & Infection Control. 2018; 7(1)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article